This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fantin, V. R. Articles by Leder, P. Search for Related Content PubMed PubMed Citation Articles by Fantin, V. R. Articles by Leder, P.

F16, a Mitochondriotoxic Compound, Triggers Apoptosis or Necrosis Depending on the Genetic Background of the Target Carcinoma Cell

Department of Genetics, Harvard Medical School and Howard Hughes Medical Institute, Boston, Massachusetts

Mutations that lead to the emergence of resistance to apoptosis are commonly observed among tumor cells. Some of the proteins affected are integral parts of the apoptotic cascade such as pro- and antiapoptotic members of the Bcl-2 family. F16 is a small molecule that accumulates in mitochondria of a variety of tumor cells and interferes with their physiological function. Because this interference ultimately triggers apoptosis in many affected cell lines, we examined the effect of antiapoptotic Bcl-2 overexpression on the response of cells to F16. Our results showed that high levels of Bcl-2 did not block the ability of F16 to induce cell death. However, unlike the apoptotic response that followed F16 treatment of cells with moderate Bcl-2 levels, cells resistant to a variety of apoptotic stimuli by virtue of Bcl-2 overexpression succumbed to F16 by necrosis. Thus, this dual ability of the mitochondriotoxic compound F16 to induce apoptosis and necrosis may represent an added advantage by expanding its spectrum of action toward genetically altered tumor cells incapable of apoptosis.

This article has been cited by other articles:

				G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF]

				C. E. Senkal, S. Ponnusamy, M. J. Rossi, K. Sundararaj, Z. Szulc, J. Bielawski, A. Bielawska, M. Meyer, B. Cobanoglu, S. Koybasi, et al. Potent Antitumor Activity of a Novel Cationic Pyridinium-Ceramide Alone or in Combination with Gemcitabine against Human Head and Neck Squamous Cell Carcinomas in Vitro and in Vivo J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1188 - 1199. [Abstract] [Full Text] [PDF]

				J. Kluza, M.-A. Gallego, A. Loyens, J.-C. Beauvillain, J.-M. F. Sousa-Faro, C. Cuevas, P. Marchetti, and C. Bailly Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin d. Cancer Res., March 15, 2006; 66(6): 3177 - 3187. [Abstract] [Full Text] [PDF]

				M. A. Brehm, K. A. Daniels, and R. M. Welsh Rapid Production of TNF-{alpha} following TCR Engagement of Naive CD8 T Cells J. Immunol., October 15, 2005; 175(8): 5043 - 5049. [Abstract] [Full Text] [PDF]

				V. R. Fantin, M. J. Berardi, H. Babbe, M. V. Michelman, C. M. Manning, and P. Leder A Bifunctional Targeted Peptide that Blocks HER-2 Tyrosine Kinase and Disables Mitochondrial Function in HER-2-Positive Carcinoma Cells Cancer Res., August 1, 2005; 65(15): 6891 - 6900. [Abstract] [Full Text] [PDF]

				D. Ramljak, L. J. Romanczyk, L. J. Metheny-Barlow, N. Thompson, V. Knezevic, M. Galperin, A. Ramesh, and R. B. Dickson Pentameric procyanidin from Theobroma cacao selectively inhibits growth of human breast cancer cells Mol. Cancer Ther., April 1, 2005; 4(4): 537 - 546. [Abstract] [Full Text] [PDF]

				R. Rotem, A. Heyfets, O. Fingrut, D. Blickstein, M. Shaklai, and E. Flescher Jasmonates: Novel Anticancer Agents Acting Directly and Selectively on Human Cancer Cell Mitochondria Cancer Res., March 1, 2005; 65(5): 1984 - 1993. [Abstract] [Full Text] [PDF]

				L. Cilenti, G. A. Kyriazis, M. M. Soundarapandian, V. Stratico, A. Yerkes, K. M. Park, A. M. Sheridan, E. S. Alnemri, J. V. Bonventre, and A. S. Zervos Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells Am J Physiol Renal Physiol, February 1, 2005; 288(2): F371 - F379. [Abstract] [Full Text] [PDF]

				L. Cilenti, M. M. Soundarapandian, G. A. Kyriazis, V. Stratico, S. Singh, S. Gupta, J. V. Bonventre, E. S. Alnemri, and A. S. Zervos Regulation of HAX-1 Anti-apoptotic Protein by Omi/HtrA2 Protease during Cell Death J. Biol. Chem., November 26, 2004; 279(48): 50295 - 50301. [Abstract] [Full Text] [PDF]